Displaying drugs 2676 - 2700 of 2767 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Valsartan | 435.5188 C24H29N5O3 | An angiotensin-receptor blocker used to manage hypertension alone or in combination with other antihypertensive agents and to manage heart failure in patients who are intolerant to ACE inhibitors. | Angiotensin II Antagonists and Calcium Channel Blockers / Angiotensin II Antagonists and Diuretics / Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics | |
Vamorolone | 356.462 C22H28O4 | A synthetic glucocorticoid used as an anti-inflammatory and immunosuppressant in the management of Duchenne muscular dystrophy (DMD). | Anti-Inflammatory Agents | |
Vanadium | 50.9415 V | A micronutrient used in some multivitamins and parenteral nutrition. | Metals, Heavy / Trace Elements / Transition Elements | |
Vancomycin | 1449.254 C66H75Cl2N9O24 | A glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections. | Anti-Bacterial Agents | |
Vandetanib | 475.354 C22H24BrFN4O2 | An antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. | Protein Kinase Inhibitors | |
Vanillyl butyl ether | 210.2695 C12H18O3 | Vanillyl butyl ether is an ether of monohydroxybenzoic acid. It is added to food products as a flavoring agent. It is also present in cosmetics and personal care products as... | Not Annotated | |
Vardenafil | 488.603 C23H32N6O4S | A phosphodiesterase 5 inhibitor used to treat erectile dysfunction. | Drugs Used in Erectile Dysfunction | |
Varenicline | 211.268 C13H13N3 | A partial agonist at nicotinic acetylcholine receptors used as an aid in smoking cessation. | Drugs Used in Nicotine Dependence | |
Vasopressin | 2140.46 C92H130N28O24S4 | A peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy. | Vasopressin and Analogues | |
Vecuronium | 557.8274 C34H57N2O4 | A nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures. | Androstanols / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists | |
Velpatasvir | 883.019 C49H54N8O8 | A NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis. | Antivirals for treatment of HCV infections | |
Vemurafenib | 489.922 C23H18ClF2N3O3S | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors / Sulfonamides | |
Venetoclax | 868.45 C45H50ClN7O7S | A BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia. | BCL-2 Inhibitor | |
Venlafaxine | 277.4018 C17H27NO2 | A selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of major depression, generalized or social anxiety disorder, and panic disorder. | Agents producing tachycardia | |
Verapamil | 454.6016 C27H38N2O4 | A non-dihydropyridine calcium channel blocker used in the treatment of angina, arrhythmia, and hypertension. | ACE Inhibitors and Calcium Channel Blockers / Phenylalkylamine Derivatives | |
Vericiguat | 426.388 C19H16F2N8O2 | A soluble guanylate cyclase stimulator used to reduce heart failure-related hospitalization and cardiovascular death in patients with chronic systolic heart failure. | Soluble Guanylate Cyclase Stimulator | |
Vernakalant | 349.471 C20H31NO4 | An antiarrhythmic medication used to treat patients with atrial fibrillation. | Antiarrhythmic agents / Antiarrhythmics, Class III / Benzene Derivatives / Cardiac Therapy / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Ethers / Methyl Ethers / Phenols / Phenyl Ethers / Potential QTc-Prolonging Agents / QTc Prolonging Agents | |
Verteporfin | 718.7942 C41H42N4O8 | A benzoporphyrin derivative used to treat pathological myopia, ocular histoplasmosis, and choroidal neovascularization in macular degeneration. | Antineovascularisation Agents | |
Vibegron | 444.535 C26H28N4O3 | A beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults. | Adrenergic Agonists / Adrenergic beta-3 Receptor Agonists / Adrenergic beta-Agonists / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs for Urinary Frequency and Incontinence / Genitourinary Smooth Muscle Relaxants / P-glycoprotein substrates / Pyrimidines / Selective Beta 3-adrenergic Agonists | |
Vidarabine | 267.2413 C10H13N5O4 | An antiviral agent used to treat various viral infections. | Antiviral Agents / Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors | |
Vigabatrin | 129.157 C6H11NO2 | An irreversible GABA transaminase inhibitor used as an adjunct therapy to treat refractory complex partial seizures in patients ≥2 years unresponsive to alternatives. May also be used as monotherapy to treat infantile spasms in infants 1 month to 2 years. | Fatty Acid Derivatives | |
Vilanterol | 486.43 C24H33Cl2NO5 | A long-acting beta2-adrenergic agonist used in combination with other bronchodilators for the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. | Agents producing tachycardia / Agents that produce hypertension | |
Vilazodone | 441.5249 C26H27N5O2 | An antidepressant agent used for the treatment of major depressive disorder that targets the 5-HT transporter and 5-HT1A receptors. | Agents that produce hypertension | |
Vildagliptin | 303.3993 C17H25N3O2 | A once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. | DPP-IV Inhibitors | |
Viloxazine | 237.299 C13H19NO3 | A selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults in children. | Adrenergic Uptake Inhibitors / Antidepressive Agents, Second-Generation / Morpholines / Norepinephrine Reuptake Inhibitor |
Displaying drugs 2676 - 2700 of 2767 in total